AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34344834 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV persistent (second consecutive HPV-positive result)
Number of subjects: 1133
Study 33547487 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Physical Activity (MPA)
Number of subjects: 366
Study 33547487 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-Vigorous Physical Activity (MVPA)
Number of subjects: 366
Study 33547487 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D)
Number of subjects: 366
Study 32071051 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime-avibactam
Number of subjects: 817
Study 32071051 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 817
Study 616191718 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex decongestive therapy (CDT) for 2 weeks
Number of subjects: 38
Study 616191718 — intervention group
Group type: EXPERIMENTAL
Intervention: Stellate ganglion block (SGB) with 3 consecutive SGBs every 2 weeks
Number of subjects: 38
Study 616191718 — intervention group
Group type: COMPARATOR
Intervention: EQ-5D score for quality of life
Number of subjects: 38
Study 616191718 — intervention group
Group type: COMPARATOR
Intervention: Subjective improvement
Number of subjects: 38
Study 35965625 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 80
Study 35965625 — intervention group
Group type: COMPARATOR
Intervention: In vitro fertilization (IVF)
Number of subjects: 80
Study 33029789 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding with fish oil (ω‐3 PUFAs)
Number of subjects: 150
Study 33029789 — intervention group
Group type: COMPARATOR
Intervention: Enteral feeding without fish oil (Control)
Number of subjects: 150
Study 34527222 — intervention group
Group type: EXPERIMENTAL
Intervention: High plasma α-carotene
Number of subjects: 0
Study 34527222 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein and zeaxanthin (combined)
Number of subjects: 0
Study 33306110 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplements
Number of subjects: 0
Study 33306110 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study 35775723 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor blocker exendin[9-39] (Ex-9)
Number of subjects: 33
Study 35775723 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP4 inhibitor (sitagliptin)
Number of subjects: 33
Study 35775723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 33043353 — intervention group
Group type: EXPERIMENTAL
Intervention: 65 μm glycine powder air-polishing (GPAP)
Number of subjects: 33
Study 33043353 — intervention group
Group type: COMPARATOR
Intervention: Rubber cup + sodium hydrogen carbonate
Number of subjects: 33
Study 34133823 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Dermabrasion (MD)
Number of subjects: 26
Study 34133823 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrofulguration-assisted Dermabrasion (EF)
Number of subjects: 26
Study 34372851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-coordinated transitional care intervention (Cardiac Care Bridge program)
Number of subjects: 16
Study 34325975 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (200 mg continuous infusion for 7 days)
Number of subjects: 405
Study 34325975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405
Study 34325975 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 405
Study 33740568 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibuprofen 400 mg
Number of subjects: 200
Study 33740568 — intervention group
Group type: COMPARATOR
Intervention: IV paracetamol 1000 mg
Number of subjects: 200
Study 32457366 — intervention group
Group type: EXPERIMENTAL
Intervention: Water spray (WS) applied every 15 minutes during exercise
Number of subjects: 27
Study 32457366 — intervention group
Group type: COMPARATOR
Intervention: Control (C) without WS
Number of subjects: 27
Study 34544170 — intervention group
Group type: EXPERIMENTAL
Intervention: Existing risk scores for bleeding in venous thromboembolism (ACCP‐VTE, HAS‐BLED, Hokusai, Kuijer, Martinez, RIETE, and VTE‐BLEED)
Number of subjects: 1046
Study 34544170 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic classification based on cancer type (gastrointestinal; genitourinary; other)
Number of subjects: 1046
Study 34544170 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly derived competing risk‐adjusted prediction model (CAT‐BLEED)
Number of subjects: 1046
Study 33755168 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose amoxicillin (875 mg) plus clavulanate (125 mg) twice a day for 7 days
Number of subjects: 157
Study 33755168 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose amoxicillin (875 mg) plus clavulanate (125 mg) plus placebo, twice a day for 7 days
Number of subjects: 157
Study 33755168 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose amoxicillin (875 mg) plus clavulanate (125 mg)
Number of subjects: 157
Study 33755168 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose amoxicillin (875 mg) plus clavulanate (125 mg) plus placebo
Number of subjects: 157
Study 34256031 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezepelumab 210 mg administered subcutaneously every 4 weeks for 28 weeks (extended to 52 weeks if needed)
Number of subjects: 250
Study 34256031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 34256031 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezepelumab
Number of subjects: 250
Study 32359153 — intervention group
Group type: EXPERIMENTAL
Intervention: USDA‐LB (150 g/d lean beef as an isocaloric replacement for carbohydrate)
Number of subjects: 33
Study 32359153 — intervention group
Group type: EXPERIMENTAL
Intervention: USDA‐LB
Number of subjects: 33
Study 32359153 — intervention group
Group type: COMPARATOR
Intervention: USDA‐CON (USDA Healthy US‐Style Eating Pattern, low in saturated fat and red meat)
Number of subjects: 33
Study 32359153 — intervention group
Group type: COMPARATOR
Intervention: USDA‐CON
Number of subjects: 33
Study 35953719 — intervention group
Group type: EXPERIMENTAL
Intervention: Obicetrapib 5 mg
Number of subjects: 120
Study 35953719 — intervention group
Group type: EXPERIMENTAL
Intervention: Obicetrapib 10 mg
Number of subjects: 120
Study 35953719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33957895 — intervention group
Group type: EXPERIMENTAL
Intervention: Physically active learning (PAL) group
Number of subjects: 2084
Study 33957895 — intervention group
Group type: EXPERIMENTAL
Intervention: Don't worry ‐ Be Happy (DWBH) group
Number of subjects: 2084
Study 33957895 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2084
Study 35577470 — intervention group
Group type: EXPERIMENTAL
Intervention: Managing Unusual Sensory Experiences (MUSE)
Number of subjects: 80
Study 35577470 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 80
Study 34314666 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Sexual Health Education Program (CSHEP)
Number of subjects: 60
Study 34314666 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study 34718932 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient AKI (Stage 1)
Number of subjects: 292
Study 34718932 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent AKI (Stage 1)
Number of subjects: 292
Study 34718932 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient AKI (Stage 2/3)
Number of subjects: 292
Study 34718932 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent AKI (Stage 2/3)
Number of subjects: 292
Study 34718932 — intervention group
Group type: COMPARATOR
Intervention: No AKI
Number of subjects: 292
Study 32151605 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-suicidal self-injury (NSSI) disorder (DSM-5)
Number of subjects: 505
Study 32151605 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-injurious behavior
Number of subjects: 505
Study 32151605 — intervention group
Group type: EXPERIMENTAL
Intervention: Impulsiveness and loneliness scores
Number of subjects: 505
Study 34420064 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 46
Study 34420064 — intervention group
Group type: COMPARATOR
Intervention: Community weight management intervention (CWI)
Number of subjects: 46
Study 34420064 — intervention group
Group type: EXPERIMENTAL
Intervention: STOP-BANG screening tool
Number of subjects: 46
Study 34420064 — intervention group
Group type: EXPERIMENTAL
Intervention: Epworth Sleepiness Scale
Number of subjects: 46
Study 34420064 — intervention group
Group type: EXPERIMENTAL
Intervention: Berlin questionnaire
Number of subjects: 46
Study 34420064 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in papilloedema
Number of subjects: 46
Study 33259454 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 cmH2O positive end-expiratory pressure
Number of subjects: 60
Study 33259454 — intervention group
Group type: COMPARATOR
Intervention: 0 cmH2O positive end-expiratory pressure (control group)
Number of subjects: 60
Study 32609084 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone (400 mg vaginal suppositories, twice daily)
Number of subjects: 4153
Study 32609084 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched vaginal suppositories)
Number of subjects: 4153
Study 32609084 — intervention group
Group type: COMPARATOR
Intervention: Cost-effectiveness analysis of Progesterone vs Placebo
Number of subjects: 4153
Study 35509855 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor‐patient‐affective disorder intervention
Number of subjects: 300
Study 35509855 — intervention group
Group type: COMPARATOR
Intervention: Routine intervention (Control)
Number of subjects: 300
Study 35291422 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI examination based on the BPSO intelligent feature optimization algorithm
Number of subjects: 120
Study 35291422 — intervention group
Group type: COMPARATOR
Intervention: Conventional MRI examination
Number of subjects: 120
Study 32051386 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-DOAC hsCRP >0.100 mg/dL
Number of subjects: 2216
Study 32051386 — intervention group
Group type: EXPERIMENTAL
Intervention: ORBIT-i score
Number of subjects: 2216
Study 34574675 — intervention group
Group type: EXPERIMENTAL
Intervention: Stone pine (Pinus cembra) solid wood beds
Number of subjects: 15
Study 34574675 — intervention group
Group type: COMPARATOR
Intervention: Chipboard beds (control)
Number of subjects: 15
Study 34574675 — intervention group
Group type: EXPERIMENTAL
Intervention: Stone pine beds
Number of subjects: 15
Study 33455419 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized intervention (OBS)
Number of subjects: 79
Study 33455419 — intervention group
Group type: COMPARATOR
Intervention: Conventional intervention (CON)
Number of subjects: 79
Study 34212138 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous and topical Tranexamic Acid (TXA)
Number of subjects: 0
Study 34212138 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal saline with epinephrine 1:100,000)
Number of subjects: 0
Study 33788216 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D status in winter (25(OH)D concentration 26.9 nmol/L)
Number of subjects: 1111
Study 33788216 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D status in summer (25(OH)D concentration 43.4 nmol/L)
Number of subjects: 1111
Study 33788216 — intervention group
Group type: EXPERIMENTAL
Intervention: Living at a latitude higher than 33°
Number of subjects: 1111
Study 33788216 — intervention group
Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 1111
Study 33788216 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D concentration in winter
Number of subjects: 1111
Study 34979503 — intervention group
Group type: EXPERIMENTAL
Intervention: Boron-based gel containing 3% sodium pentaborate pentahydrate
Number of subjects: 257
Study 34979503 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel with no chemical substance
Number of subjects: 257
Study 33962577 — intervention group
Group type: EXPERIMENTAL
Intervention: DIVERT‐CARE self‐management support and education intervention
Number of subjects: 29
Study 32232880 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI mild
Number of subjects: 176871
Study 32232880 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI non-mild
Number of subjects: 176871
Study 32232880 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD
Number of subjects: 176871
Study 32232880 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI mild with PTSD
Number of subjects: 176871
Study 32232880 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI non-mild with PTSD
Number of subjects: 176871
Study 32232880 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI mild without PTSD
Number of subjects: 176871
Study 32232880 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI non-mild without PTSD
Number of subjects: 176871
Study 36109024 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual healing in addition to usual care
Number of subjects: 28
Study 36109024 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 28
Study 33876334 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen-supplemented A-TE CXL
Number of subjects: 44
Study 33876334 — intervention group
Group type: COMPARATOR
Intervention: Room air conditions A-TE CXL
Number of subjects: 44
Study 33318317 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful awareness practice
Number of subjects: 0
Study 32962461 — intervention group
Group type: EXPERIMENTAL
Intervention: TempWatch
Number of subjects: 100
Study 33892722 — intervention group
Group type: EXPERIMENTAL
Intervention: Inofolic (4 g myo‐inositol + 400 μg folic acid)
Number of subjects: 60
Study 33892722 — intervention group
Group type: COMPARATOR
Intervention: Folic acid (400 μg)
Number of subjects: 60
Study 35645134 — intervention group
Group type: EXPERIMENTAL
Intervention: Music (group M, n=35)
Number of subjects: 70
Study 35645134 — intervention group
Group type: COMPARATOR
Intervention: Control (group C, n=35)
Number of subjects: 70
Study 33827537 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day mobilization group (mobilized when hemodynamically stable within four hours after surgery)
Number of subjects: 80
Study 33827537 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day mobilization group
Number of subjects: 80
Study 33827537 — intervention group
Group type: COMPARATOR
Intervention: Next-day mobilization group (mobilized first time in the morning of the first post-operative day)
Number of subjects: 80
Study 35114340 — intervention group
Group type: EXPERIMENTAL
Intervention: Jawarish Falafili (JF) 10 gm/day for 90 days
Number of subjects: 74
Study 35114340 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 20 mg/day for 90 days
Number of subjects: 74
Study 35818296 — intervention group
Group type: EXPERIMENTAL
Intervention: oVRcome app (self-guided virtual reality exposure and cognitive behaviour therapy)
Number of subjects: 126
Study 35818296 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 126
Study 33671071 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus subtilis DE111
Number of subjects: 0
Study 33671071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35170627 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 0.25% calcium anacardate
Number of subjects: 252
Study 35170627 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 0.50% calcium anacardate
Number of subjects: 252
Study 35170627 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 0.75% calcium anacardate
Number of subjects: 252
Study 35170627 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 1.0% calcium anacardate
Number of subjects: 252
Study 35170627 — intervention group
Group type: COMPARATOR
Intervention: Diet without growth promoter
Number of subjects: 252
Study 35170627 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 0.1% growth promoter
Number of subjects: 252
Study 36088415 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (A1 pulley disconnected at the middle)
Number of subjects: 60
Study 36088415 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (A1 pulley disconnected at the extreme radial side)
Number of subjects: 60
Study 36088415 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (A1 pulley excised)
Number of subjects: 60
Study 35907838 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention sessions on diabetes management
Number of subjects: 136
Study 33764122 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentivized ratings (monetary rewards or pro-social cues)
Number of subjects: 0
Study 33764122 — intervention group
Group type: COMPARATOR
Intervention: Voluntary reviews
Number of subjects: 0
Study 33764122 — intervention group
Group type: EXPERIMENTAL
Intervention: High monetary rewards or pro-social cues as incentives
Number of subjects: 0
Study 32380449 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS (HF group)
Number of subjects: 45
Study 32380449 — intervention group
Group type: COMPARATOR
Intervention: 1 Hz rTMS (LF group)
Number of subjects: 45
Study 32380449 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (sham group)
Number of subjects: 45
Study 34417781 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival triamcinolone acetonide (n = 36)
Number of subjects: 163
Study 34417781 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (n = 36)
Number of subjects: 163
Study 34417781 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (n = 45)
Number of subjects: 163
Study 34417781 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment (control group, n = 46)
Number of subjects: 163
Study 34632865 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual game training using the SeeMe virtual game system (12 sessions of 30 minutes bi-weekly)
Number of subjects: 31
Study 34632865 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 31
Study 32844575 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic group laughter therapy (30-minute session once weekly for 8 weeks)
Number of subjects: 151
Study 32844575 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laughter therapy)
Number of subjects: 151
Study 35893343 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-layer running suture re-anastomosis (Group 1)
Number of subjects: 36
Study 35893343 — intervention group
Group type: COMPARATOR
Intervention: Interrupted suture re-anastomosis (Group 2)
Number of subjects: 36
Study 32189678 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold chain equipment (CCEs) assessment using WHO‐UNICEF Effective Vaccine Management (EVM) tool
Number of subjects: 29
Study 32189678 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive containers
Number of subjects: 29
Study 32189678 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical vaccine storage equipment
Number of subjects: 29
Study 32189678 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive container capacity
Number of subjects: 29
Study 32189678 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice packs preparation and storage capacity
Number of subjects: 29
Study 32189678 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned preventive maintenance (PPM) of CCEs
Number of subjects: 29
Study 32189678 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard operating procedures for emergency event management
Number of subjects: 29
Study 35526121 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release (IR) risedronate taken fasted (group A)
Number of subjects: 160
Study 35526121 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 1 taken fasted (group B)
Number of subjects: 160
Study 35526121 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 2 taken fasted (group C)
Number of subjects: 160
Study 35526121 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 3 taken fasted (group D)
Number of subjects: 160
Study 35526121 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 4 taken fasted (group E)
Number of subjects: 160
Study 35526121 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 1 taken with food (group F)
Number of subjects: 160
Study 35526121 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 2 taken with food (group G)
Number of subjects: 160
Study 35526121 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 3 taken with food (group H)
Number of subjects: 160
Study 35526121 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 4 taken with food (group I)
Number of subjects: 160
Study 33292629 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal art psychotherapy
Number of subjects: 20
Study 33292629 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control
Number of subjects: 20
Study 36142086 — intervention group
Group type: EXPERIMENTAL
Intervention: Play in an upright position (45 min, three times a week for 3 months)
Number of subjects: 30
Study 34103042 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbascum Thapsus
Number of subjects: 93
Study 34103042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 32769065 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology massage for 15 minutes
Number of subjects: 120
Study 32769065 — intervention group
Group type: COMPARATOR
Intervention: Placebo or control (not specified)
Number of subjects: 120
Study 35524415 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D, n = 30)
Number of subjects: 60
Study 35524415 — intervention group
Group type: COMPARATOR
Intervention: Saline (group C, n = 30)
Number of subjects: 60
Study 34554690 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping with the space correction technique (KSCT, n = 20)
Number of subjects: 71
Study 34554690 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping with the muscle inhibition technique (KMIT, n = 24)
Number of subjects: 71
Study 34554690 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program (control group, CG, n = 27)
Number of subjects: 71